PISCATAWAY, N.J., April 19, 2010 - Sabinsa Corporation received Generally Recognized As Safe (GRAS) status for its popular patented bioavailability enhancement ingredient BioPerine^® - black pepper extract, after a comprehensive review of safety and toxicology data by an independent panel of scientists with international repute assembled by Soni & Associates, Inc.

Self-affirmed GRAS status allows manufacturers additional freedom to add BioPerine^® in a variety of foods and beverages ranging from baked goods to milk products, breakfast cereals, cheese, egg products, processed vegetables, soft candy, soups, snack foods, non-alcoholic beverages, imitation dairy products, hard candy, chewing gum, granulated sugar, and even seasonings & flavors.

PISCATAWAY, N.J., September 09, 2009 - Sabinsa Corporation has received yet another affirmation of the strength of its intellectual property rights with a recent decision by the U.S. Patent and Trademark Office (U.S. PTO) upholding U.S. Patent No. 5,972,382 (the ‘382 patent), one of the company’s patents on uses of piperine extract, which was developed by sister company Sami Labs Limited and is sold by Sabinsa as the proprietary branded ingredient, BioPerine^®.

BioPerine^®, a 98% pure piperine extract, has been the subject of numerous scientific studies, and its composition, manufacture and use are covered by several U.S. and foreign patents. BioPerine^® enhances the body’s natural thermogenic activity, which plays an integral role in utilizing the daily food and nutrients that the human body consumes. The decision on reexamination confirmed the patentability of piperine for increasing nutrient-induced thermogenesis and other nutritional uses claimed in the ‘382 patent.

Sabinsa submitted the ‘382 patent for reexamination by the U.S. PTO in 2004, aware that having the patent upheld would further discourage infringement of its intellectual property. The final U.S. PTO decision was welcomed by Sabinsa’s founder Dr. Muhammed Majeed, whose research with his scientific team formed the basis upon which the patent was founded. “We are pleased that the U.S. PTO has recognized Sabinsa’s pioneering work in the development of piperine for use in the nutritional supplement industry,” Dr. Majeed noted. “Sabinsa continues to invest in research of BioPerine^® with the knowledge that its intellectual property rights in the product are strong, and we will continue to enforce our rights against those who violate the law by infringing our patents.”

Sabinsa’s mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past 20 years, Sabinsa has brought to market more than 100 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 full time scientists conducting ongoing research in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified Kosher, with many certified Halal. For more information, visit : www.sabinsa.com & www.sabinsacosmetics.com.

PISCATAWAY, N.J., June 18, 2007 - Sabinsa Corporation today announced that it has secured a patent in Japan for its branded ingredient BioPerine^®, a standardized piperine composition derived from black pepper extract. Patent #3953513, Sabinsa’s first in Japan, protects the use of piperine as a bioavailability enhancer and affirms that BioPerine^® is the only black pepper extract that can legally be used in nutritional supplements for the purpose of enhancing the bioavailability of nutrients.

“Sabinsa pioneered the concept of enhancing nutrient absorption and bioavailability in the early 90s with the development of BioPerine^®, and we are pleased to be able to protect this intellectual property in the Japanese market,” stated Vladimir Badmaev, M.D., Ph.D., vice president of scientific and medical affairs, Sabinsa Corporation. “As the population continues to age, improving nutrient absorption and bioavailability is going to become an even more critical component in helping individuals prevent disease and maintain overall good health.”

BioPerine^® is a standardized piperine composition derived from black pepper extract that has been shown in clinical research to increase the absorption of nutrients in nutritional supplement formulations. BioPerine^® and its use are protected under U.S. Patent Nos. 5,536,506, 5,744,161, 5,972,382, and 6,054,585; European Patent No. EP0810868; Japanese Patent No. 3953513; and International Patents pending. In 1999, Sabinsa’s U.S. Patent for BioPerine^® was runner-up for the Thomas Alva Edison Patent Award, given to the most innovative patent of the year by the New Jersey R&D Council. In 2005, a related patent for BioPerine^® received the Thomas Alva Edison Patent Award. For more information on Bioperine visit www.bioperine.com.

Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals. Sabinsa’s mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past nine years, Sabinsa has brought to market more than 50 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified Kosher. For more information visit www.sabinsa.com.

PISCATAWAY, N.J., August 6, 2007 - Sabinsa Corporation today announced that it has secured a patent in Canada for its branded ingredient BioPerine^®, a standardized piperine composition derived from black pepper extract. Patent #2,247,467 protects the use of piperine as a bioavailability enhancer and affirms that BioPerine^® is the only black pepper extract that can legally be used in nutritional supplements for the purpose of enhancing the bioavailability of nutrients in Canada.

“The Canadian patent for Bioperine represents over 10 years of concerted and sustained effort, and we are particularly pleased with the successful outcome,” stated Vladimir Badmaev, M.D., Ph.D., vice president of scientific and medical affairs, Sabinsa Corporation. “With a Japanese patent recently secured and U.S. and European patents in place, we increasingly recognize the importance of actively protecting our intellectual property worldwide and preventing potential infringement.”

In addition to securing a patent for Bioperine in Canada, Sabinsa Corporation’s U.S. Patent 5,972,382 for BioPerine^® received a formal review from the US Patent and Trademark Office (USPTO), which concluded that all points outlined were valid for “Use of piperine as a bioavailability enhancer.” For more information on BioPerine^® visit www.bioperine.com.

Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals. Sabinsa’s mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past nine years, Sabinsa has brought to market more than 50 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified Kosher. For more information visit www.sabinsa.com.

BioPerine^® is a Registered Trademark and a product of Sabinsa Corp., and its use is protected under U.S. Patent Nos. 5,536,506, 5,744,161, 5,972,382, and 6,054,585; European Patent No. EP0810868; Japanese Patent No. 3953513; Canadian Patent No. 2,247,467; and International Patents pending.

May 10, 2000 PISCATAWAY, NJ - Sabinsa Corporation has been granted its fourth patent on* BioPerine^®, a proprietary ingredient which has been clinically shown to increase the bioavailibility of nutritional supplements, thus making them more effective.US patent #6,054,585 was awarded April 25, 2000. The new patent awarded to Sabinsa is a process patent, explaining how the material is made and protecting Sabinsa's patent rights. Previous patents insured Sabinsa exclusive rights to offer piperine, the active compound in BioPerine^® extracted from black pepper, regardless of its source, for use in nutritional compounds. Practically speaking, this means that no one can legally market or sell piperine for nutritional compounds except Sabinsa or its designated licensees. The only clinical studies done with piperine for nutritional purposes are with BioPerine^®.

Please contact Sabinsa Corporation for more information in New Jersey at 732-777-1111 or in Utah at 801-465-8400.

Sabinsa Corporation is an application-oriented manufacturing and marketing company which manufacturers and supplies Phytonutrients, Ayurvedic herbal extracts and specialty fine chemicals used for nutritional, pharmaceutical and food products. Sabinsa distinguishes itself by its extensive research support for its customers and products, as well as the scientific credentials of its key technical staff.

* BioPerine^® is a registered trademark of the Sabinsa Corporation

May 10, 2000 PISCATAWAY, NJ - Sabinsa Corporation's BioPerine^® trademark has been officially accepted and recognized as a trademark in Europe. Sabinsa received a Certificate of Registration 000286922 for the BioPerine^® trademark that provides protection in the 15 member states of the European Union (EU).

PISCATAWAY, NJ - Sabinsa Corporation was recently nominated for the 1999 Thomas Alva Edison Patent Award in the Health & Medical category. This award is granted annually for recognizing the worldwide impact of science and technology. Sabinsa was selected based upon its patents for BioPerine^®, a proprietary ingredient which enhances nutrient bioavailability and absorption

Other finalists included Rutgers University, Union Carbide Company, Lucent Technologies, and Bell labs. A total of eight finalists were selected. The award is bestowed by the New Jersey Research & Development Council.

Commenting on the events of the evening, Sabinsa's President and CEO Dr. Muhammed Majeed noted, "Although we didn't win the award for our category, we consider ourselves winners just for being one of the finalists. We were competing against multi-billion dollar organizations and rubbing shoulders with some of the brightest research minds in the country There were no losers here tonight."

Sabinsa Corporation, which has pioneered the introduction of several Ayurvedic herbal extracts in the US market, is an application-oriented manufacturing and marketing company which manufacturers Phytonutrients, Ayurvedic herbal extracts and fine chemicals used for nutritional, pharmaceutical, cosmeceutical and food products. Sabinsa distinguishes itself by its extensive research support for its customers and products, as well as the scientific credentials of its technical staff.

PISCATAWAY, NJ - Sabinsa Corporation has been granted a third patent on BioPerine^®, the proprietary ingredient which has been clinically shown to increase the bioavailibility of nutritional supplements, thus making them more effective.

This US patent, # 5,972,382, was granted October 26, 1999. Previous patents are US patent #5,536,506, granted July 16, 1996, and US patent # 5,744,161, granted April 28, 1998.

Piperine is the active compound extracted from black pepper which is responsible for BioPerine's bioavailability enhancing properties in nutritional compounds. The patents awarded to Sabinsa grant the company the exclusive right to offer piperine, regardless of its source, for use in nutritional compounds. Practically speaking, this means that no one can legally market or sell piperine for nutritional compounds except Sabinsa or its designated licensees.

The only clinical studies done with piperine for nutritional purposes are with BioPerine^®. BioPerine^® is the only piperine compound clinically tested for safety and efficacy. Recent studies include a March 1999 in the Nutrition Research Journal: Piperine Increases Serum Response Of Beta-Carotene During 14 Days of Oral Beta Carotene Supplementation. Another study confirmed for publication in early 2000 will appear in the Journal of Nutritional Biochemistry on CoQ10 and BioPerine^®.

BioPerine^® was designed to address the problem of limited nutrient bioavailability, which may be caused by a variety of conditions such as old age, limited diet choices or a compromised gastrointestinal tract. "The usual way these conditions are compensated for involved increased dosage. BioPerine^® provides an alternative method for improving nutritional status by increasing the amount of nutrients absorbed by the body." There are a number of companies offering finished products that include BioPerine^®. Sabinsa requires that a licensing agreement be executed with each marketing company prior to selling BioPerine^®, and that the ingredient logo appear on the label to help consumers identify products containing BioPerine^®.

In other related news, Sabinsa was recently nominated by the New Jersey R&D Council as one of three finalists for the prestigious Thomas Alva Edison Patent Award in the Health & Medical category. This award is granted annually to recognize the worldwide impact of science and technology. Sabinsa was selected based upon its patents for the use of BioPerine^®.

Sabinsa Corporation is an application-oriented manufacturing and marketing company which manufacturers and supplies Phytonutrients, Ayurvedic herbal extracts and specialty fine chemicals used for nutritional, pharmaceutical and food products. Sabinsa distinguishes itself by its extensive research support for its customers and products, as well as the scientific credentials of its key technical staff

January 29, 1999 PISCATAWAY, NJ - Sabinsa Corporation's founder Muhammed Majeed, PhD and Vice President of Scientific and Medical Affairs, Vladimir Badmaev, MD, PhD., have authored an article to appear in the peer-reviewed journal, Nutrition Research.

The article, "Piperine, an alkaloid derived from black pepper increases serum response of beta-carotene during 14 days of oral beta-carotene supplementation" to appear in Vol.19 No.3, (March 1999 pages 385-392) issue details the clinical study involving BioPerine^® and Beta-Carotene. BioPerine^® is a multi-patented ingredient from Sabinsa Corporation, standardized for a minimum 98% piperine from the fruits of the Piper nigrum plant (black pepper). BioPerine^® has been shown to increase the bioavailability of other supplements in separate clinical studies also.

Sabinsa Corporation is an application-oriented manufacturing and marketing company which manufactures and supplies quality assured phytonutrients, standardized herbal extracts and specialty fine chemicals used for nutritional, pharmaceutical and food products. Sabinsa distinguishes itself by its extensive research support for its customers and products, as well as the scientific credentials of its key staff.

NEW DELHI, INDIA - Dr. Muhammed Majeed, founder, President and CEO of Sabinsa Corporation received the President's Award for Quality and Innovation from Dr. Shankar Dayal Sharma, President of India on October 11, 1995. Sabinsa's research and manufacturing facility located in India was named company of the year.

"Dr. Majeed, your contributions ... are appreciated as a mechanism for human resource development and as an agent of change," said Dr. Sharma in presenting the award. "I hope that this award will inspire you to further achievements in the years ahead."

The company was selected because of its innovative practices, specifically for implementing the manufacturing process of L-Selenomethionine, making it one of only two companies in the world to manufacture this unique and safe form of selenium. The company was also cited for its development of Citrin^®, the first standardized Garcinia extract in the world, and BioPerine^®, which has been shown in clinical testing to improve absorption of essential nutrients with which it is formulated.

Secaucus, NJ - For the first time, a foreign company engaging in alleged Intellectual Property (IP) theft at a dietary supplements industry trade show has been stopped in its tracks.

Sabinsa Corporation, known for vigorously protecting its IP, obtained an emergency injunction from the United States District Court against Alchem International, Ltd. when it was observed that the company was offering to sell products which infringed upon two of Sabinsa's patented ingredients, ForsLean â and BioPerine â , at SupplySide East in Secaucus NJ.

According to Mark C. Sysler, Sabinsa's Sr. EVP for Marketing and Sales, defending a company's Intellectual Property against some foreign patent infringers is a struggle. These companies will attend or exhibit at a trade show, offer to sell ingredients that are protected by a US patent, and leave the country before action can be taken by the patent holder. They then follow up on those leads from overseas and it is difficult to pursue legal action against them.

In this case, Sysler went before US district Judge Pisano on Tuesday May 6, 2003, just after the trade show opened. The judge issued a temporary order restraining Alchem from

"1. Infringing Sabinsa ‘s United States patent no. 5,804,596 either directly, contributorily or by inducement, by importing, using, making, selling or offering to sell any coleus forskohlii extract in a concentration of 3% or greater, specifically including any sale, advertising, promotion, display or mention of the products at the Supply Side East trade show presently taking place at the Meadowlands Exposition center in Secaucus New Jersey and

2. from infringing Sabinsa ‘s United States patent no. 5,972,382 either directly, contributorily or by inducement, by importing, using, making, selling or offering to sell any piperine extract from black pepper in any concentration, specifically including any sale, advertising, promotion, display or mention of the products at the Supply Side East trade show presently taking place at the Meadowlands Exposition center in Secaucus New Jersey."

Sabinsa Corporation, which has pioneered the introduction of several Ayurvedic herbal extracts in the US market, is an application-oriented manufacturing and marketing company which manufacturers Phytonutrients, Ayurvedic herbal extracts and specialty fine chemicals used for nutritional, pharmaceutical, cosmeceutical and food products. Sabinsa distinguishes itself by its extensive research support for its customers and products, and the scientific credentials of its key technical staff.